BC
Broadfin Capital Portfolio holdings
AUM
$403M
This Quarter Return
+35.38%
1 Year Return
+74.97%
3 Year Return
+245.63%
5 Year Return
+336.04%
10 Year Return
–
AUM
$1.25B
AUM Growth
+$1.25B
(+9.7%)
Cap. Flow
-$132M
Cap. Flow
% of AUM
-10.5%
Top 10 Holdings %
Top 10 Hldgs %
52.28%
Holding
94
New
22
Increased
16
Reduced
21
Closed
15
Top Buys
| 1 |
ALR
Alere Inc
ALR
|
$22.1M |
| 2 |
Iovance Biotherapeutics
IOVA
|
$12.9M |
| 3 |
GNCA
Genocea Biosciences, Inc.
GNCA
|
$12.3M |
| 4 |
ADXS
Advaxis, Inc.
ADXS
|
$11.6M |
| 5 |
RXDX
Ignyta, Inc.
RXDX
|
$10.9M |
Top Sells
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$48.4M |
| 2 |
VOLC
VOLCANO CORPORATION COM STK
VOLC
|
$44.6M |
| 3 |
AMAG
AMAG Pharmaceuticals, Inc.
AMAG
|
$24.4M |
| 4 |
Assertio
ASRT
|
$22.6M |
| 5 |
KND
Kindred Healthcare
KND
|
$20.2M |
Sector Composition
| 1 | Healthcare | 94.1% |
| 2 | Consumer Discretionary | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
HZNP
1
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $183M | 14.27% | 7,053,504 -1,864,471 | -21% | -$48.4M |
|
|
AVDL
2
Avadel Pharmaceuticals
AVDL
$1.43B
| $84.9M | 6.61% | 4,719,959 -433,231 | -8% | -$7.79M |
|
3
Travere Therapeutics
TVTX
$1.56B
| $71M | 5.53% | 2,962,298 +303,444 | +11% | +$7.27M |
|
|
AEGR
4
DELISTED
Aegerion Pharmaceuticals, Inc.
AEGR
| $65.5M | 5.1% | 2,502,578 -46,285 | -2% | -$1.21M |
|
|
PGNX
5
DELISTED
Progenics Pharmaceuticals Inc
PGNX
| $53.5M | 4.17% | 8,951,169 | – | – |
|
6
Emergent Biosolutions
EBS
$443M
| $52.1M | 4.06% | 1,810,519 -256,200 | -12% | -$7.37M |
|
7
AngioDynamics
ANGO
$417M
| $42.7M | 3.32% | 2,398,527 -272,176 | -10% | -$4.84M |
|
8
Heron Therapeutics
HRTX
$207M
| $40.9M | 3.18% | 2,808,173 | – | – |
|
9
Amphastar Pharmaceuticals
AMPH
$1.42B
| $31.8M | 2.48% | 2,127,854 | – | – |
|
10
Rigel Pharmaceuticals
RIGL
$697M
| $29.4M | 2.29% | 8,246,329 -255,421 | -3% | -$912K |
|
|
BDSI
11
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $23.6M | 1.84% | 2,246,399 -150,000 | -6% | -$1.57M |
|
|
PTX
12
DELISTED
Pernix Therapeutics Holdings, Inc.
PTX
| $23.2M | 1.81% | 2,168,326 -881,674 | -29% | -$9.42M |
|
|
ALR
13
DELISTED
Alere Inc
ALR
| $22.1M | 1.72% | +452,423 | New | +$22.1M |
|
|
ACGN
14
DELISTED
Aceragen, Inc. Common Stock
ACGN
| $21M | 1.64% | 5,663,845 +2,138,145 | +61% | +$7.93M |
|
|
PETX
15
DELISTED
Aratana Therapeutics, Inc.
PETX
| $18.1M | 1.41% | 1,131,865 -127,606 | -10% | -$2.04M |
|
|
DSCI
16
DELISTED
Derma Sciences, Inc. Common Stock (DE)
DSCI
| $18M | 1.41% | 2,130,477 +273,600 | +15% | +$2.32M |
|
17
Catalyst Pharmaceutical
CPRX
$2.52B
| $17.7M | 1.38% | 4,083,177 +1,683,177 | +70% | +$7.29M |
|
|
RXDX
18
DELISTED
Ignyta, Inc.
RXDX
| $17.3M | 1.35% | 1,741,700 +1,100,000 | +171% | +$10.9M |
|
19
Dynavax Technologies
DVAX
$1.19B
| $17.2M | 1.34% | 766,010 | – | – |
|
|
20
Assertio
ASRT
$80.4M
| $15.8M | 1.23% | 705,204 -1,008,498 | -59% | -$22.6M |
|
|
ZGNX
21
DELISTED
Zogenix, Inc.
ZGNX
| $14.7M | 1.15% | 10,737,645 +4,500,000 | +72% | +$6.17M |
|
|
LJPC
22
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $12.9M | 1% | 703,470 -417,900 | -37% | -$7.65M |
|
|
23
Iovance Biotherapeutics
IOVA
$807M
| $12.9M | 1% | +1,062,419 | New | +$12.9M |
|
|
SCTL
24
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
| $12.8M | 1% | 1,413,533 | – | – |
|
|
ATRS
25
DELISTED
Antares Pharma, Inc.
ATRS
| $12.7M | 0.99% | 4,700,000 | – | – |
|